PEAR - Pear Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $2.33. This is a potential upside of $2.33 (0%) from yesterday's end of day stock price of $0.

Pear Therapeutics's activity chart (see below) currently has 10 price targets and 12 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 20-Mar-2023.

Best performing analysts who are covering PEAR - Pear Therapeutics:

Marie Thibault Keay Nakae Judah Frommer Charles Rhyee

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$8

2 years 1 months 19 days ago
(20-Mar-2023)

0/3 (0%)

$5.51 (221.29%)

Buy

$1

$0.99 (9900.00%)

$7

2 years 1 months 19 days ago
(20-Mar-2023)

0/3 (0%)

$0.79 (376.19%)

Buy

$5

2 years 1 months 22 days ago
(17-Mar-2023)

0/1 (0%)

$3 (150.00%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PEAR (Pear Therapeutics) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on PEAR (Pear Therapeutics) with a proven track record?

MARIE THIBAULT

Which analyst has the current lower performing score on PEAR (Pear Therapeutics) with a proven track record?

CHARLES RHYEE

Which analyst has the most public recommendations on PEAR (Pear Therapeutics)?

Marie Thibault works at BTIG and has 4 price targets and 3 ratings on PEAR

Which analyst is the currently most bullish on PEAR (Pear Therapeutics)?

Judah Frommer with highest potential upside - $0.99

Which analyst is the currently most reserved on PEAR (Pear Therapeutics)?

Marie Thibault with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?